EyePoint Pharmaceuticals
EYPT
EYPT
85 hedge funds and large institutions have $237M invested in EyePoint Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 84 → 85 (+1)
1% more capital invested
Capital invested by funds: $236M → $237M (+$1.29M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
85
Holding in Top 10
1
Calls
$813K
Puts
$204K
Top Buyers
| 1 | +$5.99M | |
| 2 | +$2.1M | |
| 3 | +$1.74M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$1.26M |
| 5 |
BlackRock
New York
|
+$651K |
Top Sellers
| 1 | -$5.77M | |
| 2 | -$4.76M | |
| 3 | -$760K | |
| 4 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$707K |
| 5 |
FAM
Fred Alger Management
New York
|
-$550K |